Form 4: PTC Therapeutics Director Allan Jacobson Sells Shares

Director Allan Steven Jacobson sold 1,230 shares of PTC Therapeutics (PTCT) common stock at an average price of $51.52 on March 4, 2025.

Summary

• On March 4, 2025, Allan Steven Jacobson, a director of PTC Therapeutics, Inc. (PTCT), sold 1,230 shares of common stock.
• The sale was executed at a weighted average price of $51.52 per share, with individual transactions ranging from $51.50 to $51.54.
• Following the transaction, Jacobson directly owns 19,118 shares of PTC Therapeutics common stock.

Sentiment

Score: 5

Explanation: This is a neutral disclosure of a stock sale by a company director. It doesn't inherently indicate positive or negative sentiment about the company's prospects.

Industry Context

This Form 4 filing is a routine disclosure of insider trading activity. It provides transparency into the transactions of company insiders, allowing investors to monitor potential shifts in sentiment or alignment of interests.

Stakeholder Impact

• The sale of shares by a director could be perceived negatively by some shareholders, but the relatively small number of shares sold is unlikely to have a significant impact.

Key Dates